Suppr超能文献

乳腺癌幸存者使用芳香化酶抑制剂后发生硬化性苔藓:病例报告。

Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.

机构信息

Division of General Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Women's Health Team, Fenway Health, Boston, MA, USA.

出版信息

J Gen Intern Med. 2013 Apr;28(4):592-5. doi: 10.1007/s11606-012-2209-z. Epub 2012 Sep 7.

Abstract

Lichen sclerosus is a commonly misdiagnosed disease that is characterized by thinned, hypopigmented, crinkled skin that often forms a figure-eight shape around the vaginal and anal openings. We present a case of advanced lichen sclerosus in a 53-year-old female patient prescribed a nonsteroidal aromatase inhibitor after the excision of a breast cancer tumor. We present a diagnostic approach to lichen sclerosus by recognizing its common figure-eight pattern, and we review the known causes and treatment of lichen sclerosus. Research has shown that lichen sclerosus is more common in low estrogen states, and thus it is logical that aromatase inhibitors could increase a patient's risk for developing this disease. We therefore propose that all patients prescribed aromatase inhibitors undergo regular vulvo-vaginal exams to rule out lichen sclerosus and other hypoestrogen-related vulvo-vaginal problems.

摘要

硬化性苔藓是一种常被误诊的疾病,其特征是皮肤变薄、色素减退、起皱,常常在阴道和肛门开口处形成一个数字“8”的形状。我们报告了一例 53 岁女性患者的晚期硬化性苔藓病例,该患者在切除乳腺癌肿瘤后被开处了非甾体类芳香酶抑制剂。我们通过识别其常见的数字“8”模式提出了硬化性苔藓的诊断方法,并回顾了硬化性苔藓的已知病因和治疗方法。研究表明,硬化性苔藓在低雌激素状态下更为常见,因此芳香酶抑制剂会增加患者患这种疾病的风险是合乎逻辑的。因此,我们建议所有开处芳香酶抑制剂的患者定期进行外阴阴道检查,以排除硬化性苔藓和其他与低雌激素相关的外阴阴道问题。

相似文献

1
Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
J Gen Intern Med. 2013 Apr;28(4):592-5. doi: 10.1007/s11606-012-2209-z. Epub 2012 Sep 7.
2
Lichen sclerosus in a breast cancer survivor.
J Gen Intern Med. 2013 Mar;28(3):345. doi: 10.1007/s11606-012-2318-8.
3
Lichen sclerosus in breast cancer survivor.
J Gen Intern Med. 2013 Mar;28(3):344. doi: 10.1007/s11606-012-2319-7.
5
Anastrozole-induced hepatotoxicity.
Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1233-4. doi: 10.1097/01.meg.0000243868.64078.af.
6
Changes in endocrine therapy: anastrozole and advanced breast cancer in postmenopausal women.
Am J Hosp Palliat Care. 2004 Nov-Dec;21(6):457-65. doi: 10.1177/104990910402100612.
8
Anastrozole.
Drugs Today (Barc). 2005 Apr;41(4):227-39. doi: 10.1358/dot.2005.41.4.908563.
10
Is long-term adjuvant treatment of breast cancer with anastrozole indicated?
Expert Opin Pharmacother. 2008 Jun;9(9):1619-22. doi: 10.1517/14656566.9.9.1619.

引用本文的文献

1
Advances in the pathogenesis of vulvar lichen sclerosus.
Mol Biol Rep. 2024 Mar 7;51(1):396. doi: 10.1007/s11033-024-09318-7.
2
Art of prevention: The importance of dermatologic care when using aromatase inhibitors.
Int J Womens Dermatol. 2021 Jul 17;7(5Part B):769-773. doi: 10.1016/j.ijwd.2021.07.002. eCollection 2021 Dec.
3
Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report.
Case Rep Dermatol. 2019 Feb 28;11(1):57-63. doi: 10.1159/000497469. eCollection 2019 Jan-Apr.
4
Lichen sclerosus in breast cancer survivor.
J Gen Intern Med. 2013 Mar;28(3):344. doi: 10.1007/s11606-012-2319-7.

本文引用的文献

1
Lichen sclerosus and squamous cell carcinoma.
Actas Dermosifiliogr. 2012 Jan;103(1):21-8. doi: 10.1016/j.adengl.2011.05.004. Epub 2012 Mar 24.
2
A population-based case-control study of aetiological factors associated with vulval lichen sclerosus.
J Obstet Gynaecol. 2012 Apr;32(3):271-5. doi: 10.3109/01443615.2011.649320.
3
Topical interventions for genital lichen sclerosus.
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD008240. doi: 10.1002/14651858.CD008240.pub2.
4
An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155.
J Invest Dermatol. 2012 Mar;132(3 Pt 1):658-66. doi: 10.1038/jid.2011.369. Epub 2011 Nov 24.
5
A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
J Am Acad Dermatol. 2011 Jun;64(6):e99-104. doi: 10.1016/j.jaad.2010.06.011. Epub 2011 Feb 25.
7
Vulvovaginal atrophy.
Mayo Clin Proc. 2010 Jan;85(1):87-94. doi: 10.4065/mcp.2009.0413.
8
ACOG Practice Bulletin No. 93: diagnosis and management of vulvar skin disorders.
Obstet Gynecol. 2008 May;111(5):1243-53. doi: 10.1097/AOG.0b013e31817578ba.
9
Local oestrogen for vaginal atrophy in postmenopausal women.
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001500. doi: 10.1002/14651858.CD001500.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验